Peer review reports
From: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models
Original Submission |
26 Dec 2014 |
Submitted |
Original manuscript
|
|
Author responded |
Author comments
|
|
Reviewed |
Reviewer Report
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
|
Author responded |
Author comments
|
Resubmission - Version 5 |
|
Submitted |
Manuscript version 5
|
|
Author responded |
Author comments
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
|
Author responded |
Author comments
|
Resubmission - Version 7 |
|
Submitted |
Manuscript version 7
|
Publishing |
16 Nov 2015 |
Editorially accepted |
|
1 Dec 2015 |
Article published |
10.1186/s12885-015-1936-z
|
Learn about peer review